[
1. ZHU N., ZHANG D., WANG W., LI X., YANG B., SONG J., et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020.10.1056/NEJMoa2001017709280331978945
]Search in Google Scholar
[
2. TOMASONI D., ITALIA L., ADAMO M., INCIARDI RM., LOMBARDI CM., SOLOMON SD., et al. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. European journal of heart failure. 2020;22(6):957–66.10.1002/ejhf.1871727309332412156
]Search in Google Scholar
[
3. ZHENG Y-Y., MA Y-T., ZHANG J-Y., XIE X. COVID-19 and the cardiovascular system. Nature reviews cardiology. 2020;17(5):259–60.10.1038/s41569-020-0360-5709552432139904
]Search in Google Scholar
[
4. MADJID M., SAFAVI-NAEINI P., SOLOMON SD., VARDENY O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA cardiology. 2020;5(7):831–40.10.1001/jamacardio.2020.128632219363
]Search in Google Scholar
[
5. CLERKIN KJ., FRIED JA., RAIKHELKAR J., SAYER G., GRIFFIN JM., MASOUMI A., et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–55.10.1161/CIRCULATIONAHA.120.04694132200663
]Search in Google Scholar
[
6. LIU PP., BLET A., SMYTH D., LI H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68–78.10.1161/CIRCULATIONAHA.120.04754932293910
]Search in Google Scholar
[
7. XIONG T-Y., REDWOOD S., PRENDERGAST B., CHEN M. Coronaviruses and the cardiovascular system: acute and long-term implications. European heart journal. 2020.10.1093/eurheartj/ehaa231745451332186331
]Search in Google Scholar
[
8. SHI S., QIN M., SHEN B., CAI Y., LIU T., YANG F., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology. 2020;5(7):802–10.10.1001/jamacardio.2020.0950709784132211816
]Search in Google Scholar
[
9. YANGA J., ZHENG Y., GOU X., PU K., CHEN Z., GUO Q., et al. Prevalence of comorbidity and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis. Int J Infect Dis. 2020;94:91–5.10.1016/j.ijid.2020.03.017719463832173574
]Search in Google Scholar
[
10. RUMERY K., SEO A., JIANG L., CHOUDHARY G., SHAH NR., RUDOLPH JL., et al. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure. ESC Heart Failure. 2021;8(3):2338–44.10.1002/ehf2.13291812038133728800
]Search in Google Scholar
[
11. DEFILIPPIS EM., REZA N., DONALD E., GIVERTZ MM., LINDENFELD J., JESSUP M. Considerations for heart failure care during the COVID-19 pandemic. Heart failure. 2020;8(8):681–91.
]Search in Google Scholar
[
12. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). [Internet]. Cochrane. 2022. Available from: Available from www.training.cochrane.org/handbook.
]Search in Google Scholar
[
13. YONAS E., ALWI I., PRANATA R., HUANG I., LIM MA., GUTIERREZ EJ., et al. Effect of heart failure on the outcome of COVID-19—A meta analysis and systematic review. The American journal of emergency medicine. 2021;46:204–11.10.1016/j.ajem.2020.07.009734731633071085
]Search in Google Scholar
[
14. LOMBARDI AF., AFSAHI AM., GUPTA A., GHOLAMREZANEZHAD A. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article. La radiologia medica. 2021;126(4):561–9.10.1007/s11547-020-01311-x768919033242204
]Search in Google Scholar
[
15. ZHOU B., KOJIMA S., KAWAMOTO A., FUKUSHIMA M. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. Journal of medical virology. 2021;93(5):2694–704.10.1002/jmv.2675433368358
]Search in Google Scholar
[
16. GUPTA A., MADHAVAN MV., SEHGAL K., NAIR N., MAHAJAN S., SEHRAWAT TS., et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020;26(7):1017–32.10.1038/s41591-020-0968-332651579
]Search in Google Scholar
[
17. HAUDHRY F., LAVANDERO S., XIE X., SABHARWAL B., ZHENG Y-Y., CORREA A., et al. Manipulation of ACE2 expression in COVID-19. Open Heart. 2020;7(2):e001424.10.1136/openhrt-2020-001424775741333443121
]Search in Google Scholar
[
18. BABAPOOR-FARROKHRAN S., RASEKHI RT., GILL D., BABAPOOR S., AMANULLAH A. Arrhythmia in COVID-19. SN Comprehensive Clinical Medicine. 2020;2(9):1430–5.10.1007/s42399-020-00454-2742619332838188
]Search in Google Scholar
[
19. SALEH KB., HAFIZ A., ALSULAIMAN K., ALJUHANI O., ALHARBI S., ALHARBI A., et al. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): a multicenter cohort study. American Heart Journal Plus: Cardiology Research and Practice. 2021;7:100033.
]Search in Google Scholar
[
20. TOUSOULIS D., ANTONIADES C., BOSINAKOU E., KOTSOPOULOU M., TSIOUFIS C., TENTOLOURIS C., et al. Effects of atorvastatin on reactive hyperaemia and the thrombosis–fibrinolysis system in patients with heart failure. Heart. 2005;91(1):27–31.10.1136/hrt.2003.027110176864715604328
]Search in Google Scholar
[
21. SHENOY S. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflammation research. 2020;69(11):1077–85.10.1007/s00011-020-01389-z741096232767095
]Search in Google Scholar
[
22. PAROHAN M., YAGHOUBI S., SERAJI A., JAVANBAKHT MH., SARRAF P., DJALALI M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male. 2020;23(5):1416–24.10.1080/13685538.2020.177474832508193
]Search in Google Scholar
[
23. TOMASONI D., INCIARDI RM., LOMBARDI CM., TEDINO C., AGOSTONI P., AMERI P., et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. European journal of heart failure. 2020;22(12):2238–47.10.1002/ejhf.205233179839
]Search in Google Scholar
[
24. PETRILLI CM., JONES SA., YANG J., RAJAGOPALAN H., O’DONNELL L., CHERNYAK Y., et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. bmj. 2020;369.10.1136/bmj.m1966724380132444366
]Search in Google Scholar
[
25. BOCCHI EA., LIMA IGCV., BISELLI B., SALEMI VMC., FERREIRA SMA., CHIZZOLA PR., et al. Worsening of heart failure by coronavirus disease 2019 is associated with high mortality. ESC Heart Failure. 2021;8(2):943–52.10.1002/ehf2.13199800666133498096
]Search in Google Scholar
[
26. LLÀCER P., MANZANO L., FERNÁNDEZ C., MORENO MC., NÚÑEZ J.. Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis. European Journal of Internal Medicine. 2021;88:136–8.10.1016/j.ejim.2021.02.013790651833676804
]Search in Google Scholar
[
27. RUGE M., GOMEZ JMD., DE LAVALLAZ JDF., HLEPAS A., RAHMAN A., PATEL P., et al. Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. American heart journal plus: cardiology research and practice. 2021;4:100022.10.1016/j.ahjo.2021.100022820481234151308
]Search in Google Scholar
[
28. SON M., JO YS., JO S., PARK K. Impact of COVID-19 on Heart Failure Patients in South Korea A Nationwide Population-Based Study. International Heart Journal. 2021:21–198.10.1536/ihj.21-19834544986
]Search in Google Scholar
[
29. SOKOLSKI M., TRENSON S., SOKOLSKA JM., D’AMARIO D., MEYER P., POKU NK., et al. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC heart failure. 2021;8(6):4955–67.10.1002/ehf2.13549865301434533287
]Search in Google Scholar
[
30. MURAT B., MURAT S., MERT KU., BILGIN M., CAVUSOGLU Y. Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study. Acta cardiologica. 2022;77(1):37–44.10.1080/00015385.2021.194576534218753
]Search in Google Scholar
[
31. GOYAL P., RESHETNYAK E., KHAN S., MUSSE M., NAVI BB., KIM J., et al. Clinical characteristics and outcomes of adults with a history of heart failure hospitalized for COVID-19. Circulation: Heart Failure. 2021;14(9):e008354.10.1161/CIRCHEARTFAILURE.121.008354871164134517720
]Search in Google Scholar
[
32. KUNO T., TAKAHASHI M., OBATA R., MAEDA T. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City. American heart journal. 2020;226:24–5.10.1016/j.ahj.2020.05.005722757332425197
]Search in Google Scholar
[
33. RUMERY K., SEO A., JIANG L., CHOUDHARY G., SHAH NR., RUDOLPH JL., et al. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure. ESC heart failure. 2021;8(3):2338–44.10.1002/ehf2.13291812038133728800
]Search in Google Scholar
[
34. ALVAREZ-GARCIA J., LEE S., GUPTA A., CAGLIOSTRO M., JOSHI AA., RIVASLASARTE M., et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. Journal of the American College of Cardiology. 2020;76(20):2334–48.10.1016/j.jacc.2020.09.549759876933129663
]Search in Google Scholar
[
35. BELARTE-TORNERO LC., VALDIVIELSO-MORÉ S., VICENTE ELCANO M., SOLÉ-GONZÁLEZ E., RUÍZ-BUSTILLO S., CALVO-FERNÁNDEZ A., et al. Prognostic implications of chronic heart failure and utility of NT-proBNP levels in heart failure patients with SARS-CoV-2 infection. Journal of clinical medicine. 2021;10(2):323.10.3390/jcm10020323782989933477268
]Search in Google Scholar
[
36. INCIARDI RM., ADAMO M., LUPI L., CANI DS., DI PASQUALE M., TOMASONI D., et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. European heart journal. 2020;41(19):1821–9.10.1093/eurheartj/ehaa388723920432383763
]Search in Google Scholar
[
37. CHEN T., WU D., CHEN H., YAN W., YANG D., CHEN G., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020;368.10.1136/bmj.m1091719001132217556
]Search in Google Scholar
[
38. YIN Y., ZHOU S., ZHANG X., LI Z., LIU X., JIANG C., et al. Critically ill patients with COVID-19 in China: A multicenter retrospective observational study. 2020.10.2139/ssrn.3562469
]Search in Google Scholar
[
39. BAKER K., HANRATH A., SCHIM VAN DER LOEFF I., TEE S., CAPSTICK R., MARCHITELLI G. COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis. 2020: 2020.05.14.20100834. doi: 10.1101/2020.05.14.20100834%J.medRxiv.
]Open DOISearch in Google Scholar
[
40. CARABALLO C., MCCULLOUGH M., FUERY MA., CHOUAIRI F., KEATING C., RAVINDRA NG., et al. COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system. PLoS One. 2020;15(9):e0238829.10.1371/journal.pone.0238829752690932997657
]Search in Google Scholar
[
41. HENG G., MINGLI Z., JING D., YONG Z., WEI W., WEI Z., et al. Cardiac structural and functional characteristics in patients with coronavirus disease 2019: a serial echocardiographic study. medRxiv. 2020.10.1101/2020.05.12.20095885
]Search in Google Scholar
[
42. GARIBALDI BT., FIKSEL J., MUSCHELLI J., ROBINSON M., ROUHIZADEH M., NAGY P., et al. Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region. Medrxiv. 2020.10.1101/2020.05.24.20111864
]Search in Google Scholar
[
43. LIAO X., CHEN H., WANG B., LI Z., ZHANG Z., LI W, et al. Critical care for severe COVID-19: a population-based study from a province with low case-fatality rate in China. medRxiv. 2020.
]Search in Google Scholar
[
44. PARANJPE I., RUSSAK AJ., DE FREITAS JK., LALA A., MIOTTO R., VAID A., et al. Clinical characteristics of hospitalized Covid-19 patients in New York City. MedRxiv. 2020.
]Search in Google Scholar
[
45. GIORGI ROSSI P., MARINO M., FORMISANO D., VENTURELLI F., VICENTINI M., GRILLI R. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia. Italy medRxiv. 2020;2020(13.20063545).10.1101/2020.04.13.20063545
]Search in Google Scholar
[
46. YANOVER C., MIZRAHI B., KALKSTEIN N., MARCUS K., AKIVA P., BARER Y., et al. What factors increase the risk of complications in SARS-CoV-2–infected patients? A cohort study in a Nationwide Israeli Health Organization. JMIR public health and surveillance. 2020;6(3):e20872.10.2196/20872745110932750009
]Search in Google Scholar
[
47. ARGENZIANO MG., BRUCE SL., SLATER CL., TIAO JR., BALDWIN MR., BARR RG., et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. bmj. 2020;369.10.1136/bmj.m1996725665132471884
]Search in Google Scholar
[
48. REILEV M., KRISTENSEN KB., POTTEGÅRD A., LUND LC., HALLAS J., ERNST MT., et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. International journal of epidemiology. 2020;49(5):1468–81.10.1093/ije/dyaa140749965732887982
]Search in Google Scholar
